Analytical Data
-
基因名
CYLC1
- Application
-
别名
CYLC1; CYL; CYL1Cylicin-1; Cylicin I; Multiple-band polypeptide I
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P35663
-
表达区间
1-651aa
-
氨基酸序列
MSLPRLLKVNIRTYDNSIPISESSRKSWNQKHFALTFPKPLQRGTNDKSRPLKSQITVTRHDKRKLEEGQKPAHKWIRHSFRKILQWPPIYTAAREQTPFRHLYTSKTHLKKAEYKKSKDEKGGTPLKKDSKKKGGSYATNPESKQIVEEKTKRQNEADKTPLKSSHENEQSKKSKSSSETNPESQNSKTVSKNCSQKDKKDSKNSKKTNTEFLHTKNNPKKDLKRSKTSNDPISEICSENSLNVDFLMLVGQSDDESINFDAWLRNYSQNNSKNYSLKYTKYTKKDTKKNAKKSSDAESEDSKDAKKDSKKVKKNVKKDDKKKDVKKDTESTDAESGDSKDERKDTKKDKKKLKKDDKKKDTKKYPESTDTESGDAKDARNDSRNLKKASKNDDKKKDAKKITFSTDSESELESKESQKDEKKDKKDSKTDNKKSVKNDEESTDADSEPKGDSKKGKKDEKKGKKDSKKDDKKKDAKKNAESTEMESDLELKKDKKHSKEKKGSKKDIKKDARKDTESTDAEFDESSKTGFKTSTKIKGSDTESEESLYKPGAKKKIDESDGTSANSKMEGLESKRGFRMSSKKTTFNEKGEKASTGRVPPSREKPPLPACEPSLPSPKVRRLCWCKMPPPPPKPRYAPLPEAPWIHKLL
-
分子量
71.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CYLC1, or Cyclin L1, is a member of the cyclin family of proteins that play crucial roles in the regulation of the cell cycle and gene expression. Research into CYLC1 has gained significance due to its involvement in various cellular processes, including RNA splicing and transcription regulation. Abnormalities in CYLC1 expression have been linked to several diseases, including cancer, as it can influence cell proliferation and apoptosis. Additionally, CYLC1 is known to interact with other proteins to form complexes that are essential for proper cell cycle progression and mRNA processing. Understanding the structure and function of CYLC1, along with its regulatory mechanisms, could provide insights into its role in tumorigenesis and other diseases. Consequently, researchers are investigating the potential of CYLC1 as a therapeutic target and biomarker for cancer diagnosis and treatment. Advances in recombinant protein technology have enabled the production of CYLC1 in vitro, facilitating detailed studies of its biochemical properties, interactions, and functional implications in various cellular contexts. This body of research aims to elucidate the multifaceted roles of CYLC1 in cellular homeostasis and its contributions to disease pathology, ultimately paving the way for novel therapeutic strategies.
